Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy-Reference-Cited by-同舟云学术

Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy

Published:2011-01-12 Issue:11 Volume:71 Page:1189-1197
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Huang Shu-Pin,Bao Bo-Ying,Wu Ming-Tsang,Choueiri Toni K.,Goggins William B.,Huang Chao-Yuan,Pu Yeong-Shiau,Yu Chia-Cheng,Huang Chun-Hsiung

Funder

Taiwan National Science Council

Kaohsiung Medical University Hospital

Kaohsiung Municipal Hsiao-Kang Hospital

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.21334/fullpdf

Reference40 articles.

1. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma;Crawford;N Engl J Med,1989

2. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer;Eisenberger;N Engl J Med,1998

3. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

4. Prostate specific antigen decline after antiandrogen withdrawal: The flutamide withdrawal syndrome;Kelly;J Urol,1993

5. The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer;Small;Cancer,1995

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer;Microorganisms;2024-08-12

2. Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients;The Prostate;2024-05-29

3. Case report and literature review of rezvilutamide in the treatment of hormone-sensitive prostate cancer;Frontiers in Oncology;2024-03-21

4. Hypofractionated radiation therapy combined with androgen deprivation therapy for high‐risk localized prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-03-13

5. Remission Depth in Metastatic Hormone-Sensitive Prostate Cancer Is Associated With Prognosis in Patients With Initial Prostate-Specific Antigen Values Above 100 Ng/ML;Cureus;2024-02-11